For press releases prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc. (known as Innoviva, Inc. since January 7, 2016), please visit Innoviva, Inc. Investor Relations Press Releases.
|Date||Title and Summary||View|
|Sep 8, 2014||
Theravance Biopharma Announces Positive Top-Line Results from Phase 2b Dose-Ranging Study of its Investigational LAMA, TD-4208, for the Treatment of COPD
|Aug 21, 2014|
|Aug 13, 2014|
|Jun 2, 2014||
Theravance, Inc. and Theravance Biopharma, Inc. Announce Completion of Separation of Late-Stage Partnered Respiratory Assets From Biopharmaceutical Operations